Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 40 Projects
Project # Contact PI Funding Organization Fiscal Year
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
1RF1AG067996-01A1 HAGG, SARA NIA 2021
Phospho-tau181: a new blood test to predict Alzheimer's Disease
A2020812F Thomas Kwaku Karikari BrightFocus Foundation 2020
The expanded Alzheimer’s Association quality control (QC) program for CSF and plasma biomarkers
QC CSF 3-19-624883 Blennow, Kaj Alzheimer's Association 2019
Brain-specific tau in blood as an Alzheimer Diagnostic Accelerator
GDAPB-201809-2016615 Blennow, Kaj Alzheimer's Drug Discovery Foundation 2019
Fully automated plasma assays as screening tests for Alzheimer-related amyloid β pathology
GDAPB-201809-2016862 Zetterberg, Henrik Alzheimer's Drug Discovery Foundation 2019
Cognitive decline in early stages of AD after EGCG and a multimodal therapy
18PTC-R-592192 de la Torre, Rafael Alzheimer's Association 2018
ETHERAL : Epigenetic THERapy in ALzheimer’s Disease . A multicenter, multinational, randomized, double-blind, placebo-controlled, 3-arm, 26 weeks parallel-group study to evaluate the safety, tolerability of ORY-2001 in patients with mild-moderate AD
GC-201801-2014666 Bullock, Roger Alzheimer's Drug Discovery Foundation 2018
Development of new ATF6/DREAM PPI inhibitors for the treatment of cognitive impairment in AD
ARUK-DC2017-3 Jose Naranjo Alzheimer's Research UK 2017
Therapeutic Effect of rApoA-I-Milano in an AD Model
A2017243S Guillamon, Mar BrightFocus Foundation 2017
Sativex in MCI patients at high risk of developing AD
PTC C-16-422407 Ferrer, Isidro Alzheimer's Association 2016